MBA Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
MBA Advisors's AMGN Position: Q2 2026 in Review
MBA Advisors increased its Amgen (AMGN) stake by 2.1% in Q2 2026, buying an estimated $22.6K and bringing the position to 3,168 shares worth $1.15M. The position accounts for 0.39% of the portfolio, ranked #52.
MBA Advisors first reported a position in AMGN in Q1 2021 and has held it in 22 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- MBA Advisors held 3,168 shares of Amgen worth $1.15M as of Q2 2026.
- MBA Advisors bought 66 Amgen shares in Q2 2026, an estimated $22.6K.
- Amgen made up 0.39% of MBA Advisors's portfolio in Q2 2026, its #52 holding.
- MBA Advisors first reported a position in Amgen in Q1 2021 and has held it in 22 quarters since.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on MBA Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.